Carregant...
Synthetic lethality: emerging targets and opportunities in melanoma
Great progress has been made in the treatment of melanoma through use of targeted therapies and immunotherapy. One approach that has not been fully explored is synthetic lethality, which exploits somatically acquired changes, usually driver mutations, to specifically kill tumour cells. We outline th...
Guardat en:
| Publicat a: | Pigment Cell Melanoma Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396340/ https://ncbi.nlm.nih.gov/pubmed/28097822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12573 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|